Overview

Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the bioavailability of CMX001 when administered as a tablet vs a solution and to determine the effect of a high-fat meal on CMX001 bioavailability.
Phase:
Phase 1
Details
Lead Sponsor:
Chimerix
Collaborator:
National Institutes of Health (NIH)
Treatments:
Brincidofovir